Genome British Columbia - Genome Genomics

image description
You are here:

Genome BC and BCTIA Collaborate to Support the Future of Healthtech in BC

May 5, 2016
Genome British Columbia (Genome BC) and the British Columbia Technology Industry Association (BCTIA) today announced the launch of HyperGrowth:Life, BC’s first cohort-based program designed to advance tech companies in the healthtech and life sciences industries.

Childhood asthma research receives $2 million to investigate genetic and environmental factors

May 2, 2016
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.

Genomics offers new options for stormwater treatment

April 28, 2016
Vancouver receives roughly sixty inches of rainfall each year and rainwater runoff from roadways often contains elevated levels of several metals, as well as heavy extractable petroleum hydrocarbons. Best management practices for stormwater treatment include the design and installation of engineered…

Changing the face of sepsis treatment

April 19, 2016
A new research project, funded in part by Genome British Columbia (Genome BC), Comparison of the efficacy of anti-PCSK9 biologics in the treatment of sepsis, is being led by Cyon Therapeutics Inc. (Cyon).

BC-led salmon genome collaboration publishes major findings in Nature

April 18, 2016
As of today all salmon genes, and thus opportunities to ensure sustainable farming and wild salmon management, is just a mouse click away.

Cutting-edge health care launches in the North

April 18, 2016
PRINCE GEORGE - The North today welcomed an innovative project that will improve access for British Columbia's northern population to participate in, and reap the benefits of, clinical research that will improve disease prevention, diagnosis, and treatment in specific communities.

New therapies for Ulcerative Colitis: Research advances will benefit patients and local biotech company

April 6, 2016
Ulcerative colitis (UC) is a relapsing, remitting inflammatory disease that causes diarrhea, abdominal pain, fecal urgency and incontinence. Systemic symptoms such as fever, weight loss, malaise and fatigue can also occur in more extensive disease. Current treatments are designed to suppress immune …

Lenard Boggio and Paul Terry Appointed to the Genome BC Board

March 22, 2016
Dr. Alan Winter, President and CEO of Genome British Columbia is pleased to announce the appointment of Mr. Lenard Boggio and Dr. Paul Terry to its Board of Directors.

Genome BC Bringing Public Talk and Education Outreach to Quesnel

March 15, 2016
Genome British Columbia (Genome BC) will be visiting residents and secondary students in Quesnel on Tuesday and Wednesday of this week as they bring their community engagement and student outreach programs to the area.

Connecting the Dots between Cancer, DNA & the Patient Experience Public talk explores genomic approaches to cancer

February 17, 2016
For most people, cancer hits close to home either through personal diagnosis or the experience of a family or a friend. Genomic researchers are working hard to understand how genetic information influences the disease, aiming to provide patients with more precise approaches to cancer diagnosis and t…

Genome BC Bringing Public Talk and Education Outreach to Cranbrook

February 15, 2016
Genome British Columbia (Genome BC) will be visiting residents and secondary students in Cranbrook and surrounding communities over the next couple of weeks as they bring their community engagement and student outreach programs to the area.

BC Invests Talent and Funds into International Data Sharing Effort

January 26, 2016
DNA sequencing is revolutionizing health care and with the advancement of technology it has become more affordable to accumulate vast amounts of genomic data. These large and complex datasets – often called “Big Data” – provide an essential platform that inform the provision of health care and help …

Genome BC Announces New Executive Team Member

January 4, 2016
Genome British Columbia today announced the appointment of Dr. Catalina Lopez-Correa as Vice President, Sector Development and Chief Scientific Officer (CSO).
RSS Icon